Financial report interval: 2025.07.01 - 2025.12.31
Preview: 3SBIO(01530) predict that the Revenue is 14.83 B (+195.5%), Miss estimate;the EBIT is 10.22 B (+798.1%), Miss estimate;the EPS is 3.19 (+650%), Miss estimate.